KSE - Delayed Quote KRW

Boryung Corporation (003850.KS)

10,930.00 -20.00 (-0.18%)
At close: April 26 at 3:30 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Jay Kim Chairman & CEO -- -- --
Young-Ha Kim Senior Managing Director, Director of Marketing Division and Director -- -- 1954
Ho-Young Baek Director of Operation Support Division and Director -- -- 1962
Daniel Chang Chief Executive Officer of Pharma Biz -- -- --

Boryung Corporation

Boryeong Building
136 Changgyeonggung- ro Jongno-gu
Seoul, 03127
South Korea
82 2 708 8000 https://www.boryung.co.kr
Sector: 
Healthcare

Description

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

Corporate Governance

Boryung Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Dec 27, 2023
    Ex-Dividend Date

Upcoming Events

Jul 25, 2024 - Jul 29, 2024
Boryung Corporation Earnings Call

Related Tickers